This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

1985 Resources
1985 Resources
1985 Resources
    Date
  1. HIV self-testing (HIVST) gives people—often first-time or infrequent HIV testers from underserved populations—a tool to know their HIV status. HIVST helps users overcome perceived and real barriers to provider-based HIV testing, including stigma and discrimination, especially in areas where the HIV epidemic is concentrated among key populations, young people, and men. HIVST provides a quick and confidential testing option and reflects PATH’s efforts to promote increased access to health care tools as part of self-care. Introduction and scale-up of innovative HIVST programs like those supported by PATH have accelerated new HIV case detection and linkages to antiretroviral therapy as well as increased uptake of pre-exposure prophylaxis and voluntary medical male circumcision. This brief spotlights PATH’s experience and capabilities related to HIVST across the value chain, from initial design of HIVST products to the optimization and scale of HIVST delivery models
    Published: July 2021
    Type: Resource Page
  2. This landscape of respiratory care equipment distributors across sub-Saharan Africa is intended to provide market insights into distributors in the region who can provide quality products and after-sales support. The distributors represented in this landscape were prioritized based on their geographic reach, quality assurance, and/or strong after-sales services. Each company completed a survey about their respective capabilities and engaged in follow-up discussions to further clarify their offerings. In this version (June 2021), products with stringent regulatory authority (SRA) approval were prioritized for inclusion. We will continue to build on this landscape as further engagement takes place.If your company supplies respiratory care equipment, has presence in sub-Saharan Africa, and would like to be considered for inclusion, please complete this short survey.
    Published: July 2021
    Type: Resource Page
  3. Middle-income countries not eligible for support from Gavi, the Vaccine Alliance, have been slow to introduce rotavirus vaccines, largely due to cost concerns. A PATH analysis shows that, in most cases, rotavirus vaccination is likely to be highly cost-effective and beneficial for these countries.
    Published: July 2021
    Type: Resource Page
  4. Medical oxygen has for too long been an afterthought among the competing priorities of global health. It is a World Health Organization essential medicine and necessary treatment for acute and chronic conditions alike, but inequitable access, production shortages, logistical failures, and a host of additional circumstances have inhibited the widespread adoption and consistent provision of this lifesaving resource.The COVID-19 pandemic has given added salience to the importance of medical oxygen and made stark the seriousness that a lack of access creates. As governments and health systems come to terms with the harsh realities that the pandemic has laid bare, and the resulting political capital and social engagement is mustered, there is a robust opportunity to make inroads against this inequity and help ensure that patients the world over can again breathe easy—in more ways than one.This supply intelligence brief series, Oxygen Generation and Storage, is intended to be a concise primer for decision-makers who govern, lead, support, or manage health systems and their associated facilities. Providing an overview of the key elements that define each technology—as well as key considerations related to COVID-19—it can establish a starting point for understanding the solutions available to meet a health system’s need for medical oxygen and its delivery. It should serve alongside a broader suite of planning and analytical requirements necessary for the implementation of medical oxygen solutions.
    Published: July 2021
    Type: Resource Page
  5. People at risk for or living with HIV have an elevated risk of mental health morbidities. Poor mental health among these key populations can reduce quality of life and impact care seeking, adherence to and continuation of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP)—two critical interventions for treating and preventing HIV. Seeing this gap in successful HIV care, the USAID/PATH Healthy Markets project sought to make mental health care more accessible for people at risk for or living with HIV.
    Published: July 2021
    Type: Resource Page
Load more